BCAT-IN-1(Cat No.:I045253)is a potent and selective inhibitor of branched-chain aminotransferase (BCAT), an enzyme responsible for catalyzing the transamination of branched-chain amino acids (BCAAs) into their corresponding keto acids. By suppressing BCAT activity, BCAT-IN-1 disrupts BCAA metabolism, influencing energy production, nitrogen utilization, and key signaling pathways such as mTOR. This compound is widely used in research on cancer metabolism, neurodegenerative diseases, and metabolic disorders linked to abnormal amino acid processing. Its high selectivity, strong cellular activity, and applicability in biochemical assays make it a valuable tool for probing BCAA-related metabolic regulation.